Khurram Jamil, Chief Medical Officer: Galectin Therapeutics GALT Sell · Filed 06/30

Trade details

Type: Insider sale
Amount: $239,233.68
Shares · price: 47,467 sh · $5.04 a share
Held after: 0 sh
Stock: Galectin Therapeutics GALT
Person: Khurram JamilChief Medical Officer
Trade date: 26/06/29
Filed: 26/06/30
Days to filing: 1 days

Sold 100.0% of holdings

Share of holding sold: 100.0%

Galectin Therapeutics trades, last 26 weeks

What else happened in Galectin Therapeutics around then

Filed or reported within 30 days of the trade day · 05/30~07/29

Khurram Jamil's recent trades

Khurram JamilChief Medical Officer
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 plan
Galectin Therapeutics
GALT
$12.7K
2,533 sh
$12.7K
Filed 06/30
Traded 06/26
Khurram JamilChief Medical Officer
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 plan
Galectin Therapeutics
GALT
$10.2K
2,037 sh
$10.2K
Filed 06/30
Traded 06/26
Khurram JamilChief Medical Officer
Planned sale10b5-1 planGalectin Therapeutics
Planned sale10b5-1 plan
Galectin Therapeutics
GALT
$341.4K
68,287 sh
$341.4K
Filed 06/26
Traded 06/26
Khurram JamilChief Medical Officer
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 plan
Galectin Therapeutics
GALT
$23.7K
7,557 sh
$23.7K
Filed 06/25
Traded 06/23
Khurram JamilChief Medical Officer
Planned sale10b5-1 planGalectin Therapeutics
Planned sale10b5-1 plan
Galectin Therapeutics
GALT
$25.5K
8,125 sh
$25.5K
Filed 06/23
Traded 06/23